Pharmacological and pharmaceutical technological overview for seborrheic dermatitis: A review about topical application and new approaches

Creative Commons License

Öztürk A. A., Yenilmez E.

Acta Pharmaceutica Sciencia, vol.56, no.4, pp.57-80, 2018 (Scopus) identifier

  • Publication Type: Article / Review
  • Volume: 56 Issue: 4
  • Publication Date: 2018
  • Doi Number: 10.23893/1307-2080.aps.05626
  • Journal Name: Acta Pharmaceutica Sciencia
  • Journal Indexes: Scopus
  • Page Numbers: pp.57-80
  • Keywords: Formulation, Seborrheic dermatitis, Topical applications
  • Anadolu University Affiliated: Yes


Seborrheic dermatitis (SD) is a skin disease with chronic recurrent erythematous plaques in areas where sebaceous glands are intense. The etiology of SD remains unknown, although many factors such as lipophilic yeasts of the Malassezia genus, hormones, genetic, environmental and general health factors have been shown to be causative. SD is affecting body parts involving rich sebaceous glands such as head and skin. Treatment options include application of anti-inflammatory, antifungal, keratolytic, and sebosupressive agents. The SD causes are briefly mentioned in this review. Then, detailed information was given about the medicines used in SD treatment. The most important element of this article is to be used in SD treatment; new approaches such as new formulations, new active substances and narrow band UV rays have been mentioned. Finally, some examples of the Pharmacist’s role in SD treatment in general are given.